Caligan Partners’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Hold |
2,342,609
| – | – | 2.03% | 11 |
|
|
2025
Q1 | $10.4M | Buy |
2,342,609
+574,627
| +33% | +$2.55M | 2.17% | 12 |
|
|
2024
Q4 | $13.8M | Buy |
1,767,982
+572,729
| +48% | +$4.48M | 3.51% | 9 |
|
|
2024
Q3 | $15.7M | Buy |
1,195,253
+613,175
| +105% | +$8.06M | 4.98% | 8 |
|
|
2024
Q2 | $7.03M | Sell |
582,078
-5,198
| -0.9% | -$62.8K | 1.64% | 11 |
|
|
2024
Q1 | $9.55M | Sell |
587,276
-461,149
| -44% | -$7.5M | 2.52% | 9 |
|
|
2023
Q4 | $7.15M | Buy |
1,048,425
+1,025,104
| +4,396% | +$6.99M | 2.41% | 8 |
|
|
2023
Q3 | $127K | Buy |
+23,321
| New | +$127K | 0.06% | 11 |
|